A phase II study of cis-diamminedichloroplatinum II for advanced breast cancer. Two dose schedules. 1984

S Martino, and B A Samal, and A Singhakowinta, and S Yoshida, and M Mackenzie, and J Jain, and V K Vaitkevicius

Thirty-six (36) women with metastatic breast cancer refractory to conventional therapies were treated with cis-diamminedichloroplatinum II. Two dose schedules were used sequentially. The first 15 patients received platinum at a dose of 15 mg/m2 daily for 5 days at 28-day intervals. No response was noted in this group. Subsequently, 21 patients were treated with a dose of 100-120 mg/m2 at 28-day intervals, but with additional induced diuresis with saline, furosemide, and mannitol. Among 13 patients evaluable for response, 2 partial responses were observed.

UI MeSH Term Description Entries
D007263 Infusions, Parenteral The administration of liquid medication, nutrient, or other fluid through some other route than the alimentary canal, usually over minutes or hours, either by gravity flow or often by infusion pumping. Intra-Abdominal Infusions,Intraperitoneal Infusions,Parenteral Infusions,Peritoneal Infusions,Infusion, Intra-Abdominal,Infusion, Intraperitoneal,Infusion, Parenteral,Infusion, Peritoneal,Infusions, Intra-Abdominal,Infusions, Intraperitoneal,Infusions, Peritoneal,Intra Abdominal Infusions,Intra-Abdominal Infusion,Intraperitoneal Infusion,Parenteral Infusion,Peritoneal Infusion
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D008353 Mannitol A diuretic and renal diagnostic aid related to sorbitol. It has little significant energy value as it is largely eliminated from the body before any metabolism can take place. It can be used to treat oliguria associated with kidney failure or other manifestations of inadequate renal function and has been used for determination of glomerular filtration rate. Mannitol is also commonly used as a research tool in cell biological studies, usually to control osmolarity. (L)-Mannitol,Osmitrol,Osmofundin
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009362 Neoplasm Metastasis The transfer of a neoplasm from one organ or part of the body to another remote from the primary site. Metastase,Metastasis,Metastases, Neoplasm,Metastasis, Neoplasm,Neoplasm Metastases,Metastases
D001855 Bone Marrow Diseases Diseases involving the BONE MARROW. Bone Marrow Disease,Disease, Bone Marrow,Diseases, Bone Marrow,Marrow Disease, Bone,Marrow Diseases, Bone
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast
D002945 Cisplatin An inorganic and water-soluble platinum complex. After undergoing hydrolysis, it reacts with DNA to produce both intra and interstrand crosslinks. These crosslinks appear to impair replication and transcription of DNA. The cytotoxicity of cisplatin correlates with cellular arrest in the G2 phase of the cell cycle. Platinum Diamminodichloride,cis-Diamminedichloroplatinum(II),cis-Dichlorodiammineplatinum(II),Biocisplatinum,Dichlorodiammineplatinum,NSC-119875,Platidiam,Platino,Platinol,cis-Diamminedichloroplatinum,cis-Platinum,Diamminodichloride, Platinum,cis Diamminedichloroplatinum,cis Platinum
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation

Related Publications

S Martino, and B A Samal, and A Singhakowinta, and S Yoshida, and M Mackenzie, and J Jain, and V K Vaitkevicius
March 1982, Gan to kagaku ryoho. Cancer & chemotherapy,
S Martino, and B A Samal, and A Singhakowinta, and S Yoshida, and M Mackenzie, and J Jain, and V K Vaitkevicius
January 1980, Cancer treatment reports,
S Martino, and B A Samal, and A Singhakowinta, and S Yoshida, and M Mackenzie, and J Jain, and V K Vaitkevicius
December 1978, The Journal of urology,
S Martino, and B A Samal, and A Singhakowinta, and S Yoshida, and M Mackenzie, and J Jain, and V K Vaitkevicius
March 1978, Cancer treatment reports,
S Martino, and B A Samal, and A Singhakowinta, and S Yoshida, and M Mackenzie, and J Jain, and V K Vaitkevicius
July 1980, Schweizerische medizinische Wochenschrift,
S Martino, and B A Samal, and A Singhakowinta, and S Yoshida, and M Mackenzie, and J Jain, and V K Vaitkevicius
April 1982, Gan to kagaku ryoho. Cancer & chemotherapy,
S Martino, and B A Samal, and A Singhakowinta, and S Yoshida, and M Mackenzie, and J Jain, and V K Vaitkevicius
January 1982, Gan to kagaku ryoho. Cancer & chemotherapy,
S Martino, and B A Samal, and A Singhakowinta, and S Yoshida, and M Mackenzie, and J Jain, and V K Vaitkevicius
November 1976, Cancer treatment reports,
S Martino, and B A Samal, and A Singhakowinta, and S Yoshida, and M Mackenzie, and J Jain, and V K Vaitkevicius
January 1981, Medical and pediatric oncology,
S Martino, and B A Samal, and A Singhakowinta, and S Yoshida, and M Mackenzie, and J Jain, and V K Vaitkevicius
January 1984, Head & neck surgery,
Copied contents to your clipboard!